These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11875412)
1. Real options for biotechnology valuation. Harrison M; Lerer L Nat Biotechnol; 2002 Mar; 20(3):223-4. PubMed ID: 11875412 [No Abstract] [Full Text] [Related]
13. Biotechnology unscathed in Korean finance crisis? Saegusa A Nat Biotechnol; 1998 Feb; 16(2):151. PubMed ID: 9487520 [No Abstract] [Full Text] [Related]
14. Fragmentation is industry obstacle in Europe. Mitchell P Nat Biotechnol; 2001 Jun; 19(6):494-5. PubMed ID: 11385414 [No Abstract] [Full Text] [Related]
15. The number on biotech indexes. Jacobs T Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059 [No Abstract] [Full Text] [Related]
16. Kick-starting biotechnology in Ontario. Endersby JM Nat Biotechnol; 1999 May; 17(5):444-6. PubMed ID: 10331800 [No Abstract] [Full Text] [Related]
17. State of the biotech sector - 2006. Lawrence S Nat Biotechnol; 2007 Jul; 25(7):706. PubMed ID: 17621283 [No Abstract] [Full Text] [Related]
18. What a stock analyst can do for you. Jacobs T Nat Biotechnol; 2005 Sep; 23(9):1063. PubMed ID: 16151392 [No Abstract] [Full Text] [Related]